In addition, terminal level of plasma MIP-1α (Fig. 3b, P = 0.0002) and TNF-α (Fig. 2c, P = 0.0001) was significantly lower in SIV/Statin Group 2 compared with SIV-PAH+ controls. This evidence concerns the gene CCL3 and pulmonary arterial hypertension.